Document Detail

Detection of N-terminal pro-corticotrophin releasing hormone (CRH) and a 'novel' CRH in human maternal plasma and placenta.
MedLine Citation:
PMID:  10736245     Owner:  NLM     Status:  MEDLINE    
Corticotrophin-releasing hormone (CRH) is released from the human placenta in high concentrations towards the end of the third trimester of pregnancy, but relative concentrations of other cleavage products derived from the CRH prohormone are unknown. We have measured CRH and N-terminal (1-100) and (1-127) proCRH peptides in maternal plasma in the second and third trimesters of pregnancy and in term placental extract using immunoradiometric assays (IRMAs) specific to different regions of the CRH precursor. Levels of N-terminal proCRH (amino acid residues 1-100) rose from 24+/-4 pmol/l (mean+/-s.e.) in the second trimester to 378.8+/-65 pmol/l (mean+/-s.e.) at term. Levels of intact proCRH and/or (1-127) proCRH remained relatively constant throughout the second and third trimesters, with a concentration of 29.3+/-3.8 pmol/l (mean+/-s.e.). In the course of this work a novel form of CRH that cross-reacts within specific CRH immunoassays was observed. The use of two IRMAs developed for CRH (1-41) having different C-terminal epitope specificities provided evidence for two types of CRH coexisting in maternal plasma. Separation of term placental extract by HPLC and application of the two CRH IRMAs revealed two peaks of immunoreactivity one of which coeluted with synthetic CRH (1-41).
T C Sanderson; R J Woods; C F Kemp; P J Lowry
Related Documents :
16487435 - Apolipoprotein e genotype is related to plasma levels of c-reactive protein and lipids ...
16077175 - Secretion of leptin throughout pregnancy and early postpartum period in japanese monkey...
12189365 - Citalopram in pregnancy and lactation.
19736615 - Evidence of maternal platelet activation, excessive thrombin generation, and high amnio...
22292525 - Bovine lactoferrin in preventing preterm delivery associated with sterile inflammation ...
10607945 - Ultrasound screening for fetal chromosome anomalies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Placenta     Volume:  21     ISSN:  0143-4004     ISO Abbreviation:  Placenta     Publication Date:    2000 Mar-Apr
Date Detail:
Created Date:  2000-05-25     Completed Date:  2000-05-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8006349     Medline TA:  Placenta     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  218-25     Citation Subset:  IM    
Copyright Information:
Copyright 2000 Harcourt Publishers Ltd.
School of Animal and Microbial Sciences, University of Reading, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Corticotropin-Releasing Hormone / blood*,  immunology,  metabolism*
Cross Reactions
Immunoradiometric Assay
Peptide Fragments / blood*,  immunology,  metabolism*
Placenta / metabolism*
Pregnancy / blood*,  metabolism*
Protein Precursors / blood*,  immunology,  metabolism*
Reg. No./Substance:
0/Peptide Fragments; 0/Protein Precursors; 0/pro-corticotropin releasing hormone; 9015-71-8/Corticotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differential regulation in human amnion epithelial and fibroblast cells of prostaglandin E(2) produc...
Next Document:  Immunohistochemical localization of ECE-1 in the human placenta.